Podcasts about Aspect

Burnie and Ashley discuss lava floors, new shoes, the gun counter, TSA massages, Neil Blompkamp's AI movie, District 10, Elysium, Odyssey, IMAX aspect ratios, Prime reconfigures ad free, pillar boxes, and getting back together.

Sports guru Jon Anderson joined Ross Stevenson and Russel Howcroft to talk all things sport.See omnystudio.com/listener for privacy information.

Sports guru Jon Anderson joined Ross Stevenson and Russel Howcroft to talk all things sport.See omnystudio.com/listener for privacy information.

Dan Wiederer and guest host Ruthie Polinsky of CHSN discuss what aspects of Bears quarterback Caleb Williams' development they are most intrigued by heading into the 2026 season.

High Timeline Living Website:https://www.hightimelineliving.com/Readings with Kristin Lawhead:https://kristiraeastrology.wixsite.com/blogKristin's Pinterest Page:https://www.pinterest.com/kristirae01/?invite_code=abac4e48864546c5be3de92dd3aeea4d&sender=236439186595387133Readings with Alisa Dixon: https://www.astrologywithalisa.com/Fun Astrology YouTube Channel:https://www.youtube.com/@funastrologypodcastBuy Thomas a Coffee!https://www.buymeacoffee.com/funastrologyThank you!Join the Fun Astrology Lucky Stars Club Here!Old Soul / New Soul Podcast - Back Episodes:https://www.buzzsprout.com/2190199https://www.youtube.com/@OldSoulNewSoulAstrologyPodcastMusic: Creative Commons Bensound.com "Funky Element" - https://www.bensound.com/royalty-free-music/track/funky-elementDisclaimer: The material in this episode is intended as informational and educational purposes only from an astrological perspective and reflects only the opinions of the presenter. In no way is this podcast considered professional psychological or medical counseling or advice. If you are experiencing a personal crisis, please contact 988 for immediate professional, licensed assistance. 

Entertainment reporter Peter Ford joined Ross Stevenson and Russel Howcroft to discuss the latest news in the world of entertainment.See omnystudio.com/listener for privacy information.

Entertainment reporter Peter Ford joined Ross Stevenson and Russel Howcroft to discuss the latest in the entertainment industry.See omnystudio.com/listener for privacy information.

Entertainment reporter Peter Ford told Jimmy Bartel and Mark Allen he was confused by the clear absence of one particular member of Prince Harry’s family.See omnystudio.com/listener for privacy information.

Hvorfor føler så mange seg alene i det de står i? Hva skjer når sårbarhet, avvisning og ensomhet ikke får et sted å høre til? Hvordan kan vi få det bedre i vanskelige perioder av livet?Dette er noen av temaene vi dykker inn i, i dagens episode med Jimmy Westerheim. Jimmy er grunnlegger og daglig leder av The Human Aspect, et globalt prosjekt som samler menneskers historier om motgang, psykisk helse og hva som hjelper oss videre når livet blir vanskelig.I denne episoden går vi inn på blant annet:Hvorfor følelsen av å stå alene ofte er langt vanligere enn vi trorHva hundrevis av livshistorier har lært Jimmy om psykisk helse, motstandskraft og helingHvordan oppvekst, avvisning og relasjoner former selvbildet vårt gjennom livetHva som ligger bak fremveksten av manosphere-bevegelsen og hvorfor den appellerer til mange unge mennHva er det unge menn egentlig leter etter i dagens samfunn?Hvordan polariseringen mellom maskulinitet og femininitet kan gjøre utfordringene størreHvorfor sårbarhet, tilhørighet og mening er avgjørende for god psykisk helseHvordan bearbeide følelserHvordan tørre å være oss selvHvordan vi kan skape mer ro i nervesystemet og få flere øyeblikk av «rest and digest» i hverdagenFor mer fra Jimmy Westerheim:instagram.com/jimmywesterheimthehumanaspect.comPodcasten: HverdagspsykenØnsker deg en nydelig uke!AnnetteFølg meg gjerne på:Instagram.com/dr.annettedraglandFacebook.com/drannettedraglandhttps://youtube.com/@drannetteDisclaimer: Innholdet i podcasten og på denne nettsiden er ikke ment å utgjøre eller være en erstatning for profesjonell medisinsk rådgivning, diagnose eller behandling. Søk alltid råd fra legen din eller annet kvalifisert helsepersonell hvis du har spørsmål angående en medisinsk tilstand. Hosted on Acast. See acast.com/privacy for more information.

Rapid advances in acute ischemic stroke care have expanded treatment windows and improved patient outcomes through thrombolysis, mechanical thrombectomy, and optimized antithrombotic strategies. This episode highlights evolving approaches to patient selection, the growing role of tenecteplase, and the importance of team-based systems of care in delivering timely, effective treatment. In this episode, Casey S. Albin, MD, FAAN, speaks with Christopher R. Leon Guerrero, MD, author of the article "Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Leon Guerrero is an associate professor of neurology and the adult neurology residency program director at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, where he also serves as outpatient stroke director. Additional Resources Read the article: Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Albin: In stroke care, every minute kills nearly two million neurons. But today, we're going to unpack all the details about the latest treatments that can give those neurons back.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Albin: Hello and welcome. This is Dr. Casey Albin. Today, I'm interviewing Dr. Christopher Leon-Guerrero about his article on Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast. I always like to start by just having you introduce yourself so our listeners know a little bit about you.  Dr Leon-Guerrero: Thanks for the introduction, Dr. Albin. Really glad to be here today. My name is Chris Leon-Guerrero. I'm a vascular neurologist at Atrium Health in Charlotte, North Carolina, at Carolinas Medical Center. I'm an associate professor in the Department of Neurology. I serve as our Neurology Residency Program Director, and I also wear the hat of an outpatient stroke director in our clinics.  Dr Albin: So, you are wearing a lot of hats and balancing a lot of things, and it's a really exciting time to be talking about this. For our listeners, we are recording this right after the launch of the American Heart Association, American Stroke Association just released their new guidelines on acute ischemic care. So, no better time to kind of dive into some of this. And really, when I think about acute ischemic stroke care, it's dramatically transformed in the last two to three decades. I mean, from lengthening time windows for IV thrombolysis to expanded thrombectomy eligibility, this is really, I think, some of the most exciting stuff in neurology. And your article did a fantastic job of distilling those rapid advancements and clarifying some of the evidence behind some of these new evolving treatment selections and imaging modalities, and it's exciting. So, let's just start with thrombolysis. Where are we now with IV thrombolytics and the time windows there?  Dr Leon-Guerrero: So, a lot has changed in the last decade, since that initial trial with NINDS, nearly thirty years ago. We're still giving intravenous thrombolysis in the traditional time window up to 4.5 hours, and really emphasizing we should be selecting patients for treatment early and quickly as possible. In most of those cases, a non-con head CT is sufficient to rule out bleeding and initiate treatment as quickly as possible. Where things have gotten really exciting is using advanced neuroimaging to help select patients beyond that traditional 4.5 hour window, and we're able to treat patients even up to twenty-four hours from symptom onset.  Dr Albin: Which is really exciting. It has really totally shifted the paradigm here. You know, I think most listeners are going to be pretty familiar with three to four and a half hours. Like, that's sort of our standard. What can you tell us about some of the advanced imaging we're using for that later selection period?  Dr Leon-Guerrero: It's around the principle of you want to be able to, uh, rescue significant salvageable tissue without a lot of core. So, this large profusion deficit and small core is really how you're trying to select out these patients. And two types of modalities are used. One is going to be MRI, and a lot of those imaging protocols, you know, are outlined in the WAKE UP trial and basically are looking for patients with DWI hyperintense lesions and FLAIR negative lesions to suggest that patients in an early time window that's treatable for thrombolysis. And then in the other category, we'll be using profusion imaging, whether that's CT profusion or MR profusion, to look for patients with large salvageable tissue.  Dr Albin: Yeah. And I think that this has been one of the things that, to me, has been really impactful is I think when WAKE UP came out, it was exciting. It was fun to sort of think about, "Hey, we're going to be able to use MRI." But MRI can be very challenging to get acutely, especially in community centers where they don't have the capabilities to get someone from the emergency department into an MRI rapidly enough to make thrombolysis decisions. So, to see some of that expand to CT profusion has been really exciting. How are you going about sort of counseling patients or thinking about their risk when you're using some of those, like, advanced imaging techniques?  Dr Leon-Guerrero: Yeah. I think it's similar to the conversations we've had with patients even within the traditional 4.5 hour window. The risk for intravenous thrombolysis is hemorrhage, and counseling patients on the, you know, the risk and benefits of hemorrhage and the potential clinical benefit of receiving thrombolytics is important. And then providing patients with that information to make an informed decision, so that they can make the best decision for their own care.  Dr Albin: Totally. And it's, again, time sensitive, but trying to give families enough information and enough time to sort of process those, especially when it's a little bit beyond the standard that we're so used to consenting for. The other big area that's really changed is that tenecteplase has become the star of the show. It's really gained momentum, so what should clinicians understand about this?  Dr Leon-Guerrero: Yeah. There's been an explosion of data over the last decade on tenecteplase supporting its use for clinical practice. You know, there was recent updates even from the neurology journal with a large meta-analysis with all of the data showing good clinical outcomes and perhaps even lower risk of bleeding. And so, I think you're seeing a lot of centers across the country switching from alteplase to tenecteplase. There's some practical advantages. So tenecteplase is a one-time bolus dose. And then biologically, it seems to have better fibrin specificity, longer half-life, which may ultimately make it a more attractive drug and may make it even more effective. But I think the practical aspects of tenecteplase are not to be understated. I think there's a lot of advantages for speed and efficiency and for centers to make that switch.  Dr Albin: Yeah. I remember when our health system made the pivot from alteplase to tenecteplase. Like any changes, that obviously created some adjustments with the new workflow. But, the fact that this could be given just as a one-time dose and not with the "we got to calculate the bolus, and now we got to get the infusion on board," like really simplified workflow. So, I think that's been pragmatically one of the nicest things we've done in stroke care. Really exciting.  Dr Leon-Guerrero: Yeah. And, you know, it's a doable thing. I think you have to be, very deliberate about it at whatever center you're at to make sure that all stakeholders are aware of that change. I think that's helpful to get everybody involved and have a lot of planning to avoid wrong dosing errors or inadvertently dosing as alteplase versus tenecteplase. But it's certainly doable, and I think in the long term, centers that have switched have been pretty satisfied with tenecteplase.  Dr Albin: And you know, initially when this came out, there really was sort of a debate about, is it gonna be 0.25? Was it gonna be 0.4? Where have we landed with that debate?  Dr Leon-Guerrero: So, I think we found the correct dose is 0.25 milligrams per kilogram is the recommended dose with a max out of 25 milligrams. There's some within the American Heart Association guidelines that were just published. They mentioned even tier dosing based on 10 kilograms, so intervals. So, that may be an easier way for centers to do it. But that cap out dose of 25 milligrams at 0.25 milligrams per kilogram, I think, is the sweet spot.  Dr Albin: Yeah. That's great, and I think that that has helped, you know, say, "This is what we're doing. There's not a debate that's happening anymore." And that really just got codified in the new ASA guidelines, so really exciting there. So, there is a lot of guidance for these patients, but I think one of the things that your article really tackled is the fact that there are some special populations, where we really still don't have a lot of guidance. And so, I think just to kind of distill those for the listeners, thinking about our pregnant patients, thinking about children, how are we approaching thrombolysis decisions in these special populations?  Dr Leon-Guerrero: These are always tough cases. For example, for pregnant women, they've often been excluded in the thrombolytic trials. But there's still evidence. You know, there's some inference based on the evidence we do have, and there's a lot of registry and case reports suggesting potential safe treatment for pregnant women. And I think when you're approaching those cases, again, it's gonna be patient-centered and really should be multidisciplinary. These are the types of cases you really need to lean on your maternal fetal medicine colleagues, your high-risk OBGYNs, your obstetricians to help with that decision-making. And I think, a multidisciplinary approach is the way to go for these cases. It's the same thing with the pediatric population. We had some data. There was one trial, randomized control trial, called TIPS trial that looked at using intravenous alteplase for acute ischemic stroke in patients under the age of 18. It had difficulty with enrollment. But I think most experts would argue that patients with pediatric stroke should be considered for intravenous thrombolysis if appropriate. Again, same thing. You want to make it a multidisciplinary approach, really getting your pediatric neurologists, your pediatricians involved early to make the best decision for the patient.  Dr Albin: Yeah. That's just really an important takeaway, just thinking about this as a multidisciplinary decision, because there are going to be other stakeholders to the patient's care who may have some different information than what we as neurologists are bringing to the approach. And obviously, our perspective really matters. But trying to work in everyone's unique vantage point of the patient really helps to make the most effective decision. When we talk about acute ischemic stroke care, I really don't think that you could do justice to the topic without pivoting to mechanical thrombectomy, which, you know, as we think about how the medical field as a whole, not just neurology, how the medical field has evolved. I mean, there's probably no bigger impact than mechanical thrombectomy has made in terms of reducing not just morbidity, but mortality from stroke. I mean both. So, thrombectomy has been around for a while, but just walk our listeners through what's the core that we for sure know that these are the patients that this works for?  Dr Leon-Guerrero: The types of patients we should be selecting for intervention are patients with large vessel occlusions. And those initial trials that were published in 2015 really demonstrated that this is a quite an effective treatment for patients with large vessel occlusion ischemic strokes in the anterior circulation. When that smattering of publications occurred in 2015, the general consensus, we should be treating all patients up to six hours from symptom onset if they do have a large vessel occlusion. And then, Dr. Albin, as you know, the, the windows continue to expand. So, we were using advanced neuroimaging with MR selection and perfusion selection based on DAWN and DEFUSE 3 trial protocols to select patients all the way out to the 24 window, and it's even expanded beyond that over the last few years.  Dr Albin: I think that when we think about trials that really, totally, changed the game, when we think about DAWN and DEFUSE 3, and we switched from that time-based window to more of that, like we talked about for thrombolysis, that tissue-based clock and, like, looking at what is salvageable and where can we make an impact on salvageable tissue, truly moved the needle in terms of just bringing this therapy for people who, you know, it's hard to get in within six hours. When we moved the needle to 24, it made a huge difference. But people were still coming in with a lot of ischemic damage already done, and they would have traditionally been excluded from being enrolled in thrombectomy trials. But that's changing too. So where are we there?  Dr Leon-Guerrero: Yeah. I think there were lessons learned from DEFUSE and DAWN that we were probably over-selecting. Perhaps too stringent. You know, we had number needed to treat in the range of two to three for good outcome based on those trials. And so, I think those were lessons learned to move forward, and we, and, and people started looking at large core infarctions. And in the last few years, we've seen a multitude of randomized control trials examining large core infarctions. These are patients with ASPECT scores all the way down to zeros. A lot of the trials relied on three to six as their score, but there was at least one large core study that looked at ASPECT scores down to zero to two, and all of these studies showing benefit.  Dr Albin: Yeah. And we've really moved into if there's some tissue to spare there, probably getting clot out really makes a big difference in impact. You know, it was really surprising to me as a neurointensivist looking at these trials, that the trials had such low rates of hemorrhage, and pretty low rates of dramatic cerebral edema after thrombectomy. I don't know that we've seen all of that in sort of real world applications, but again, we are still seeing some of these patients come in, that really would've been devastated having some amount of functional recovery regained, which is incredible. In terms of another patient population that I think gives a lot of people pause or stickiness, is those basilar artery occlusions, right? Another large vessel, but one that we've had a little bit harder of a time enrolling in trials and having well-selected trials. Where are we now on whether or not basilar artery occlusion should go to mechanical thrombectomy?  Dr Leon-Guerrero: So, a lot of excitement in this area, too. There's at least two studies that were published in the last five years that were showing benefit in doing thrombectomy for patients with basilar artery occlusion up to 24 hours, and these were patients with moderate to severe deficits with NIH Stroke Scale scores greater than 10. And then making sure that they don't have large core, so using a newer scoring algorithm on the CAT scan called PC ASPECT, so basically a posterior circulation ASPECT score, to kind of make sure that patients don't have large core infarctions that are being considered for thrombectomy. All of those things collectively in those two recent studies, the ATTENTION trial and the BAOCHI trial, I think is what ended up making those studies positive, is that we were selecting the right types of patients, uh, without large core, early core, and patients with moderate to severe deficits that made the difference from previous trials.  Dr Albin: Yeah. I think that that's so important. Those trials to me, and like how long it took to get those enrolled, really emphasized to me that there really was a selection bias. Like, we believed this worked, which made it hard to then do a trial. But I'm so glad to hear that we have the data now to support moving forward in a more rigorous way.  Dr Leon-Guerrero: You're absolutely right. I think that was some of the challenges with the initial trials. In fact, the authors had commented on that. There's a lot of difficulties with lack of clinical equipoise, or experts wanting to take these patients anyways out of clinical trial and treat them, and so that's always been an issue. And then, you know, we all remember basilar artery occlusion cases. They can be severe, devastating cases in our career, but the reality is they're not that common. So, if you look at large vessel occlusions, they only account for about 10%, and if you look at all stroke patients presenting to most centers, they represent about 1% of cases. So really hard clinical trials to do just because there's thankfully not a lot of patients walking around with basilar artery occlusions, but certainly makes for challenges when you're trying to conduct randomized controlled trials on this subset of patients.  Dr Albin: Absolutely. But we did it, and I think that, like, really if, if the listeners take nothing else, it's that the field of vascular neurology is really moving forward with evidence-based, doing very rigorously controlled clinical trials, which is, I think, is what makes this field so exciting. Finally, closing out, cause we could talk all day, but we don't have all day. You know, it seems to me that more and more we are just using dual antiplatelet therapy all the time. And maybe that is, uh, a little bit of a hyperbole, cause I don't think it's all the time, but let's walk through— when is there good evidence for dual antiplatelet therapy?  Dr Leon-Guerrero: Yeah. So, there's strong evidence for early initiation of dual antiplatelet therapy or DAPT in patients with minor stroke or high-risk TIAs, and it's been studied using both clopidogrel as an add-on to aspirin and ticagrelor. Both seem like they're viable options in patients. I think one of the key things is the duration of therapy. So, in these cases with minor stroke and high-risk TIAs, we really should be confining the treatment of early DAPT for 21 days. The risk profile changes, so the risk of recurrent stroke starts to decline with time, and that risk of hemorrhage complications increases with time. And so that sweet spot of 21 days, or even some centers will do 30 days for just practical purposes, you know, really is what we should be doing in most of those cases. Other instances where DAPT can be considered, is in patients with intracranial atherosclerosis that's symptomatic, extrapolating from the SAMMPRIS trial that in the, in the medical management arm alone, used dual antiplatelet therapy with aspirin and clopidogrel for up to 90 days. So, you'll see that as well in clinical practice. Some people will opt for a 90-day duration for those patients with symptomatic intracranial atherosclerosis and stroke.  Dr Albin: Just so I emphasize, this is not set it and forget it. You can stay on DAPT forever. It is you're going to have a definitive time course, 21 days, 90 days. We have directed instructions where we're doing more benefit than harm because of that risk of hemorrhage.  Dr Leon-Guerrero: That's correct. In most cases, we really should be confining the duration of DAPT either to 21 days or 90 days. This is a challenging clinical practice. Centers really have been making an emphasis on stroke follow-up, so making sure these patients get appropriate and timely stroke follow-up to address these issues and to make sure that DAPT is discontinued if appropriate.  Dr Albin: Yeah. I love that, and I want to pull on that a little bit because you as someone who is helping direct a stroke center– A lot of this really does rely on systems of care. When we think about early lysis decisions or mechanical thrombectomy, it's how do we get the patient to one of those capable centers as quickly as possible? And then on the back end, when you're discharging a patient, how do you make sure that they are getting follow-up, making sure that they're getting their Holter monitor if they need it? You know, all the stuff that goes into kind of figuring out, why did the stroke happen? What are some of the things that you, in your role, are really excited about, that will move the needle over the next five or 10 years?  Dr Leon-Guerrero: Yeah. I think a lot of centers are doing it just like we're doing it. It really has to be a team-based approach, and you really want to reach the patient where they are in terms of the continuum of care. And so making sure if it's the in the field that you've reached out to your EMS and first responders to make sure they understand triage protocols to get patients where they need to be, to get the acute treatments that they need for the type of stroke that they're presenting with, to the actual centers that you work at, making sure your whole team, nurses, emergency physicians, APPs that are involved in care are all aware of the stroke protocols and how we're selecting these patients, making sure that your imaging protocols are up to date, and so that it's seamless when patients come in, that we're not adding on perfusion if we should have gotten that up front– We already know, have made decisions before that patient gets there. And then thinking about the patient after that hospital stay, I think, is critical. We really want to reduce their risk of recurrence, making sure that we're leveraging transitions of care, getting those patients seen in our stroke clinics for follow-up, and then make sure we're passing that baton to the long term. All of their long-term comorbidities that may be increasing their risk of stroke are managed and reduced as best as possible.  Dr Albin: From the Continuum journal to the continuum of stroke care.  Dr Leon-Guerrero: That's right.  Dr Albin: I mean, we have it all. I think that that really is so important. I'll just close with what's one thing that is your favorite part about being a vascular neurologist?  Dr Leon-Guerrero: I think it's what attracted to me to this field. As a medical student at that time, all we had was intravenous thrombolysis, and there was so much promise. There was so much promise that there was going to be widespread advancements in acute stroke, and here we are. There's been a tremendous amount of advancements and improvements for patients. I'm really excited to see what unfolds in the next few years, and I'm really excited that we've been able to increase the number of patients we're able to treat with acute ischemic stroke. I hope that we continue to expand the time window, the inclusion criteria, all of those things that we can treat more stroke patients effectively.  Dr Albin: It is really a very exciting time to be a vascular neurologist. Again, today, I've been interviewing Dr. Christopher Leon-Guerrero about his article on Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you again, Dr. Leon Guerrero and our listeners for joining today.  Dr Leon-Guerrero: Thanks for having me.  Dr Monteith: This is Dr. Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Un menu consistant ce matin autour de Valérie Expert ! Aspect politique de la canicule ; Bruno Retailleau en colère contre la date de l'élection présidentielle; Un congé parental rallongé pour une relance de la natalité ?

Trying to attract more of the right students? Narrowing down your niche or your dream client?It all comes back to one thing: your words.In this episode I break down the most important thing to focus on that will ensure more flow and abundance in your business. Everything will become easier — creating content, building your offers, and most importantly, attracting and signing on your DREAM students!You can have the best systems, great offers, and be a phenomenal teacher. But if your words aren't doing the work of articulating all of this, nobody will ever find out how good you actually are. Learn how I went from attracting "anyone who wants to sing" to the dreamiest, best students I've ever had — all with my words.This is the final part of the Voice Your Brand series!Join Voice Your Brand inside the Voicepreneur Program here: www.thevoicepreneur.com/programLINKS:Join the Voicepreneur Program (all courses + community)(Voice Your Brand program exclusively offered in VP)Join the Email Club!The Voicepreneur WebsiteThe Shop (all products + programs)Instagram @thevoicepreneurCoaching Services with AllieRESOURCES:Free Guide: Messaging Guide for Voice TeachersFree Guide: What You Need to Scale Your StudioFree Training: How to Make Passive Income Without Burning OutThe Profitable Content Guide for Voice TeachersCOURSES: Studio ShiftAmplifyThe Scaling Studio System Sell With Soul

Learning Weekly From Rabeinu Nachman ben Faiga Simcha in Likutei Moharan 46 at Shirat David Efrat. Clapping is an Aspect of Matrimony Union & Zivug in Soulful Sweet Tefilah aka Prayer. Lets learn from the Master of Prayer how to effectively and intimately daven...Cover

The Orioles will play their 81st game of the season tonight. That's a good time to step back and evaluate the team through this point. Bob, Vinny and Nolan picked their biggest disappointment of the year so far.

3AW Mornings host Tom Elliott described a new detail that had been revealed about the filming of the Victorian machete ban ad campaign as “a bit strange”.See omnystudio.com/listener for privacy information.

Gold Coast midfielder Touk Miller joined us after the loss on Friday night.See omnystudio.com/listener for privacy information.

Episode Highlights With ToddWhat quantum energy actually is and how Todd went from skeptic to deep understanding How this term gets misused a lot and the important things to actually understandWhat quantum entanglement is and how this can benefit us practically The 2022 Nobel Prize in Physics was awarded to Zellinger, Clauser and Aspect for proving quantum entanglement, but how it actually worksHow they do experiments at a distance on HRV and how they can see results remotely and rapidly Why quantum energy is neutralizing energy and doesn't need to add anything but neutralizes disruptive energy- and their experiments with this and neutralizing EMFs effects on the bodyQuantum upgrade vs leela quantum physical products and how they work the same and differentlyWhy Katie is running Quantum Upgrade on her podcast recording room and has the Blocs in her wellness center and homeHow they saw a 10% increase in HRV with quantum upgrade They see an increase in wound healing and ATP productionDr. Dru covered a study they did on 5G and what it does to the brain and HRV- improving alpha brain waves and reducing beta and gamma, which is measurableResources Mentioned Quantum Upgrade free trial - 15-day FREE trial, no credit card required with code WELLNESSMAMA15LeelaQHiyaHiya created a super powered chewable vitamin for kids that packs twelve organic fruits and vegetables plus fifteen essential vitamins and minerals into every dose. Try it at hiyahealth.com/wellnessmama for 50% off your first order.

Khemasuri introduces the Bodhisattva Ideal, central to Mahayana Buddhism, by describing the training of the novice Bodhisattva and the arising of the will to Enlightenment. Excerpted from the talk entitled Becoming a Bodhisattva given at Sheffield Buddhist Centre, 2012. *** Help us keep FBA Podcasts free for everyone! Donate now Subscribe to our Dharmabytes podcast: Bite-sized clips - Buddhist inspiration three times a week. Apple Podcasts | Spotify | YouTube

3AW Mornings host Shane McInnes described some of the conditions being demanded as “not realistic”.See omnystudio.com/listener for privacy information.

3AW Mornings host Heidi Murphy said the evidence showing support for One Nation continues to grow.See omnystudio.com/listener for privacy information.

(Auckland Insight Meditation)

(Auckland Insight Meditation)

A shortened show for Chris and Amy ahead of Cardinals baseball. They kick off the show with a recap of the Knicks comeback win; Jordan Walker has been powering the Cardinals; CITY SC is set to host watch parties for the World Cup; Matt Pauley wonders if enough All Star voters will recognize Jordan Walker; NewsNation's Kellie Meyer updates from Washington, DC.

WBEN's Tom Puckett on the legal aspect of a data center moratorium full 57 Fri, 05 Jun 2026 07:59:00 +0000 MMu2CYoTRKKvypf8a0dal9OZVBYEPZ87 news & politics,news WBEN Extras news & politics,news WBEN's Tom Puckett on the legal aspect of a data center moratorium Archive of various reports and news events 2024 © 2021 Audacy, Inc. News & Politics News https://player.amperwavepodc

Entertainment reporter Peter Ford has once again discussed the upcoming John Farnham tribute concert at Rod Laver Arena in September.See omnystudio.com/listener for privacy information.

The 3AW Drive host had an interesting opening to her program today!See omnystudio.com/listener for privacy information.

Tom Elliott had some strong views on Premier Jacinta Allan's IBAC backflip on Monday afternoon.See omnystudio.com/listener for privacy information.

Hour 2 - The medical aspect of Rashee's knee is in question + No right hand full 2865 Fri, 29 May 2026 18:57:21 +0000 28fWXpF8KxXgdBCA7GE4iY4cbBLXnWmg nfl,mlb,kansas city chiefs,kansas city royals,society & culture Cody & Gold nfl,mlb,kansas city chiefs,kansas city royals,society & culture Hour 2 - The medical aspect of Rashee's knee is in question + No right hand Hosts Cody Tapp & Alex Gold team up for 96.5 The Fan Radio's newest mid-day show "Cody & Gold."  Two born & raised Kansas Citians, Cody & Gold have been through all the highs and lows as a KC sports fan and they know the passion Kansas City has for their sports teams."Cody & Gold" will be a show focused on smart, sports conversation with the best voices from KC and around the country. It will also feature our listeners with your calls, texts & tweets as we want you to be a part of the show, not just a listener.  Cody & Gold, weekdays 10a-2p on 610 Sports Radio.  2024 © 2021 Audacy, Inc. Society & Culture https://player.ampe

Carlos Walden, former collegiate athlete and current public speaker and owner of Bully Ceazon Fitness, joins the show to give his story on how he began to find out more about his mental health and its effects along with how he uses his platform and his business to help other athletes along their journey.#mentalhealthawareness #mentalhealth #life

House music at its best! Let Dave Baker take you on a journey of discovery and aural pleasure as he brings you the hottest and freshest releases across the house music spectrum every week, including funky, deep, mainstream, melodic and tech house. Whether you're a DJ looking for the latest and hottest club cuts or you're simply a house music lover that is looking for a true house music journey, we've got all your needs covered with 2 hours of sweet grooves, deep house flavours, pumping tech house beats and even a little afro house at the end. And just for fun, a bit of Super Mario - let's-a-go! 22 out of 36 tracks aren't on public release at the time this episode is live so if you pick this up quickly, you may hear a lot of music here before you hear it anywhere else! Tracks released on May 15 unless shown. 1. Take Your Time (Do It Tonight) (Original Extended Mix) - Per QX & Stephan Duy [Walk Of Shame]

In this episode I look at how we can make health fun. Many people find it hard to get going with healthy habits andI look at ways we can make them easier to access without thinking of them as ‘health'.Monkey brain and bad habits: https://podcasts.apple.com/gb/podcast/saving-lives-in-slow-motion/id1573742958?i=1000597803315Nushu circles: https://digitize.library.ubc.ca/2025/04/10/nushu-chinas-secret-language-of-women-in-our-open-collection/Padel benefits: https://www.ltapadel.org.uk/play/benefits-of-playing-padel/Queens College Step Test: https://www.youtube.com/watch?v=ySQ5bawZpMoDancing benefits: https://www.bbc.co.uk/programmes/articles/1Hpr6R1f4M7f8Qc6fPGH2hg/why-dancing-is-the-best-way-to-enhance-your-brain-and-fitnessKeep dancing: https://www.uclahealth.org/news/article/keep-dancing-preserve-memoryThe IDEAL framework from my book: https://www.glamourmagazine.co.uk/article/the-health-fix-dr-ayan-panja-new-years-resolutionsSave your life in slow motion and those of others by subscribing now and sharing. Thank you for listening and for your support. It means a lot to me. Hosted on Acast. See acast.com/privacy for more information.

Protect your family with our 1-minute free parent quiz https://www.smartsocial.com/newsletter   Join our next weekly live parent events:  https://smartsocial.com/events   Episode Summary:   Join host Josh Ochs on the SmartSocial.com Podcast as he talks with Dr. Dionel Waters, Executive Director for IDEA Public Schools Dallas–Fort Worth, about why AI conversations with students have to stay grounded in real human connection. Dr. Waters breaks down the student struggles schools are seeing right now, including mental health concerns, attendance challenges tied to late-night screen time, and the way social feeds can shape body image and self-worth, especially for young girls.   They also dig into the future of student AI use, including why districts cannot focus only on cheating, and why parents and educators need to understand how students are using AI for relational support when they feel lonely. Dr. Waters shares guardrails that prioritize privacy, transparency, and safety, while also protecting the “human aspect” students still need from trusted adults and real relationships.   Become a Smart Social VIP (Very Informed Parents) Member: https://SmartSocial.com/vip   District Leaders: Schedule a free phone consultation to get ideas on how to protect your students in your community https://smartsocial.com/partner   Download the free Smart Social app: https://www.smartsocial.com/appdownload   Learn about the top 190+ popular teen apps: https://smartsocial.com/app-guide-parents-teachers/   View the top parental control software: https://smartsocial.com/parental-control-software/   The SmartSocial.com Podcast helps parents and educators to keep their kids safe on social media, so they can Shine Online™    

Protect your family with our 1-minute free parent quiz https://www.smartsocial.com/newsletter Join our next weekly live parent events:  https://smartsocial.com/events Episode Summary: Join host Josh Ochs on the SmartSocial.com Podcast as he talks with Dr. Dionel Waters, Executive Director for IDEA Public Schools Dallas–Fort Worth, about why AI conversations with students have to stay grounded in real human connection. Dr. Waters breaks down the student struggles schools are seeing right now, including mental health concerns, attendance challenges tied to late-night screen time, and the way social feeds can shape body image and self-worth, especially for young girls. They also dig into the future of student AI use, including why districts cannot focus only on cheating, and why parents and educators need to understand how students are using AI for relational support when they feel lonely. Dr. Waters shares guardrails that prioritize privacy, transparency, and safety, while also protecting the “human aspect” students still need from trusted adults and real relationships. Become a Smart Social VIP (Very Informed Parents) Member: https://SmartSocial.com/vip District Leaders: Schedule a free phone consultation to get ideas on how to protect your students in your community https://smartsocial.com/partner Download the free Smart Social app: https://www.smartsocial.com/appdownload Learn about the top 190+ popular teen apps: https://smartsocial.com/app-guide-parents-teachers/ View the top parental control software: https://smartsocial.com/parental-control-software/ The SmartSocial.com Podcast helps parents and educators to keep their kids safe on social media, so they can Shine Online™

Elbridge Colby explains that the binding strategy addresses the psychological aspect of war by preparing for the resolve and morale required for a larger conflict. It aims to force China into a dilemma: accept the status quo or take actions that inevitably catalyze the coalition's collective resolve. By integrating the defense of allies like Japan and Australia, the U.S. ensures that a Chinese move against Taiwan precipitates a wider war China would likely lose. This strategy leverages Thumos, or spiritedness, to ensure that Chinese aggression triggers a "don't tread on me" reaction from nationalistic regional powers. (7/8)SEPTEMBER 1932

Head over to ⁠⁠8020BASEBALL.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get even more useful coaching and baseball information, and check out the one-of-a-kind ‘8020Baseball Coaching System'.While you're there, sign up for the free one-page key takeaways PDF that summarizes all the key points of each episode and is delivered to your inbox each week for free. ⚾ ⚾ ⚾ ⚾ ⚾ Welcome to the 8020 Baseball Podcast! In this fast-paced, weekly podcast, Coach Bo shares a direct path to becoming a great youth baseball coach by combining his 20+ years of baseball coaching experience with his 20+ years of unique teaching experience, while also drawing on his experiences playing youth, HS, collegiate, and professional baseball.A deep level of baseball knowledge, combined with universal strategies such as the 80/20 Principle, gives this podcast a uniquely advanced approach to mastering all the key parts of coaching youth baseball.The podcast combines solo episodes with high-quality interviews featuring individuals who share specific, actionable strategies for youth baseball coaches. New episodes every Tuesday!

Leila Rahimi and Marshall Harris discussed a variety of topics in the 5 On It segment.

Jeff Malec sits down with Christopher Reeve, Chief Investment Officer of Aspect Capital, one of the original managed futures shops with roots tracing back to the "L" in AHL. Chris shares his path from chemistry and early-2000s AI at Oxford to 22 years at Aspect, where he now runs the investment side of the business. Jeff puts every trend following critique on the table, too big, too simple, too crowded, just beta, and Chris pushes back on all of it. They dig into why the edge is real but small, why multi-model diversification is the whole game, and why stacking lookalike models is fake diversification dressed up in a lab coat. The conversation covers cocoa and silver finally paying off, the replicator debate, why bond futures are really just seven yield curves in a trench coat, the case against explicit stops, and prediction markets.Plus King Charles, horses, chickens, and the Superman jokes that write themselves. - SEND IT!Chapters:00:00-01:21=Intro01:22-11:00= From Oxford AI and Chemistry to Building a Managed Futures Powerhouse11:01-18:51= Is Trend Following Too Big and Too Simple? Edges, Critics, and the Evolution of Models18:52-27:49= Designing Durable Trend: Multi‑Model Diversification, Modulators, and the Real Meaning of Crisis Alpha27:50-35:39= Correlated Trendlessness, Crisis Alpha Expectations, and Why Aspect Refused to “Optimize” for the Last Decade35:40-44:05= From Silver to Cocoa: Why Obscure and Alternative Markets Supercharge Trend Diversification44:06-52:04= Replicators, Bond Pain, and the Illusion of Fixed-Income Diversification52:05-01:00:25= How Aspect Sizes Positions, Builds Macro Models, and Lives with Real-World Risk01:00:26-01:06:42= Systematic Macro, Horses, and “Hair‑Dryer Alpha” in Prediction MarketsFrom the Episode: Hi Ho Silver PostTrend Following's Bond ProblemThe History of Managed Futures (whitepaper)Follow along with Christopher Reeve & Aspect Capital on LinkedIn and be sure to check out aspectcapital.com for more information!Don't forget to subscribe to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Derivative⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, follow us on Twitter at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@rcmAlts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠sign-up for our blog digest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.rcmalternatives.com/disclaimer⁠⁠⁠⁠

“What is the most beautiful aspect of Catholic faith?” This question opens a discussion on the profound elements of faith that often go uncommunicated in apologetics. The conversation also touches on how to rekindle a personal relationship with God after conversion, finding beauty in the Mass despite familiarity, and responding to evangelical critiques. Join the Catholic Answers Live Club Newsletter Invite our apologists to speak at your parish! Visit Catholicanswersspeakers.com Questions Covered: 06:20 – What is the most beautiful aspect of the Catholic faith that you didn't think you were communicating while doing apologetics? 18:50 – I'm in a similar situation. I converted due to a relationship but now I'm all head knowledge. How do I get back to the relationship part? 42:38 – How do you find beauty in the mass when you've gone all your life and have almost become desensitized to it? 49:00 – How would you respond to evangelical counters to what you’re saying?

Hour One - Calls and Reactions Hour Two - Don Logan of the SNSHOF, Howard Belzer on NFL DraftSee omnystudio.com/listener for privacy information.

Vessantara explores Sangharakshita's idea that fundamentally there is one spiritual experience, which has different aspects that we can unfold. Here he guides on how to contact and influence deeper levels of mind, culminating in the turning about of the basis, the transformation of the deepest level of mind. This talk was given at Cambridge Buddhist Centre, 2016, as part of the series Aspects of Going For Refuge (Remastered). *** Help us keep FBA Podcasts free for everyone! Donate now: https://freebuddhistaudio.com/donate Subscribe to our Free Buddhist Audio podcast: A full, curated, quality Dharma talk, every week. Apple Podcasts: https://podcasts.apple.com/us/podcast/dharmabytes-from-free-buddhist-audio/id416832097 Spotify: https://open.spotify.com/show/4UHPDj01UH6ptj8FObwBfB YouTube: https://www.youtube.com/@FreeBuddhistAudio1967

Giving is a form of worship, and it is intrinsically tied to your faith.  You are either a person who would hold something back from God or a person who has been changed by Him and gives without coercion.  Don't get puffed up in pride over your giving.  God wants you to give with your heart and to have an authentic relationship with Him.  God will bless you in intangible ways, and He will not forsake you. VF-2331 Watch, Listen and Learn 24x7 at PastorMelissaScott.com Pastor Melissa Scott teaches from Faith Center in Glendale. Call 1-800-338-3030 24x7 to leave a message for Pastor Scott. You may make reservations to attend a live service, leave a prayer request or make a commitment. Pastor Scott appreciates messages and reads them often during live broadcasts. Follow @Pastor_Scott on Twitter and visit her official Facebook page @Pastor.M.Scott. Download Pastor Scott's "Understand the Bible" app for iPhone, iPad and iPod at the Apple App Store and for Android devices in the Google Store. Pastor Scott can also be seen 24x7 on Roku and Amazon Fire on the "Understand the Bible?" channel. ©2026 Pastor Melissa Scott, Ph.D., All Rights Reserved

Red team exercises set goals to see if a particular outcome can be accomplished through a simulated attack, but the ultimate outcome should be educating the org about how to improve tools and processes that make attacks more difficult to succeed. Gwyddon "Data" Owen shares his experience building a red team, creating an exercise, and leveraging the results to improve security. And while the adoption of LLMs will accelerate a red team's activities, there are still plenty of foundational security controls that orgs can establish that would require a red team to be more than just fast, but fast and very careful. Coding Agents Are Getting More Cautious, But Not Safer A new study finds that while frontier AI coding models are hallucinating less than they did a year ago, they still preserve a significant amount of avoidable software risk when left ungrounded. Sonatype's research shows that connecting these models to real-time software intelligence dramatically improves remediation quality and reduces critical and high-severity vulnerability exposure by 60–70%. The takeaway is clear: safer AI-assisted development will depend not just on better models, but on grounding them in accurate, current dependency and vulnerability data. This segment is sponsored by Sonatype. Read the study: https://securityweekly.com/sonatypersac How We Achieve Agentic Outcomes in CyberSecurity: The “Do-It-For-Me” Mobile Defense If you look at deepfakes, synthetic identity, social engineering, and new malware variants coming to market, it seems like attackers have a first-mover advantage in using AI. The volume and variety of threats are growing faster than the current cyber stack can address. Against this backdrop, organizations are moving away from “do-it-yourself” delivery models (more tools, more alerts, more headcount) to “do-it-for-me” agentic AI delivery models (using platforms that unify data, execute policy, and automate outcomes). The emphasis outside of cyber is on empowering the expert human-in-the-loop — so teams spend less time in the noise and more time delivering business outcomes. This segment explores how cybersecurity leaders can make the most of the AI Age, leveraging it for good while staying relevant amid the explosive AI adoption curve. This segment is sponsored by Appdome. Visit https://securityweekly.com/appdomersac to learn more about them! Visit https://www.securityweekly.com/asw for all the latest episodes! Show Notes: https://securityweekly.com/asw-379

(00:00) Zolak & Bertrand start the hour by questioning the morality angle of the Mike Vrabel and Dianna Russini drama.(10:48) The crew goes back and forth with callers on whether Vrabel's statement will help or hurt the situation.(22:09) We finish the hour with MassLive's Karen Guregian calling in to break down Mike Vrabel's press conference.(33:32) Today's TakeawaysSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Red team exercises set goals to see if a particular outcome can be accomplished through a simulated attack, but the ultimate outcome should be educating the org about how to improve tools and processes that make attacks more difficult to succeed. Gwyddon "Data" Owen shares his experience building a red team, creating an exercise, and leveraging the results to improve security. And while the adoption of LLMs will accelerate a red team's activities, there are still plenty of foundational security controls that orgs can establish that would require a red team to be more than just fast, but fast and very careful. Coding Agents Are Getting More Cautious, But Not Safer A new study finds that while frontier AI coding models are hallucinating less than they did a year ago, they still preserve a significant amount of avoidable software risk when left ungrounded. Sonatype's research shows that connecting these models to real-time software intelligence dramatically improves remediation quality and reduces critical and high-severity vulnerability exposure by 60–70%. The takeaway is clear: safer AI-assisted development will depend not just on better models, but on grounding them in accurate, current dependency and vulnerability data. This segment is sponsored by Sonatype. Read the study: https://securityweekly.com/sonatypersac How We Achieve Agentic Outcomes in CyberSecurity: The "Do-It-For-Me" Mobile Defense If you look at deepfakes, synthetic identity, social engineering, and new malware variants coming to market, it seems like attackers have a first-mover advantage in using AI. The volume and variety of threats are growing faster than the current cyber stack can address. Against this backdrop, organizations are moving away from "do-it-yourself" delivery models (more tools, more alerts, more headcount) to "do-it-for-me" agentic AI delivery models (using platforms that unify data, execute policy, and automate outcomes). The emphasis outside of cyber is on empowering the expert human-in-the-loop — so teams spend less time in the noise and more time delivering business outcomes. This segment explores how cybersecurity leaders can make the most of the AI Age, leveraging it for good while staying relevant amid the explosive AI adoption curve. This segment is sponsored by Appdome. Visit https://securityweekly.com/appdomersac to learn more about them! Show Notes: https://securityweekly.com/asw-379

High Timeline Living Website:https://www.hightimelineliving.com/Readings with Kristinhttps://kristiraeastrology.wixsite.com/blogFun Astrology YouTube Channel:https://www.youtube.com/@funastrologypodcastBuy Thomas a Coffee!https://www.buymeacoffee.com/funastrologyThank you!Join the Fun Astrology Lucky Stars Club Here!Old Soul / New Soul Podcast - Back Episodes:https://www.buzzsprout.com/2190199https://www.youtube.com/@OldSoulNewSoulAstrologyPodcast